[Leiomyosarcoma and liposarcoma: rare tumors of the kidney].
Sarcoma accounts for 2.8% of all renal tumours. We report a case of renal leiomyosarcoma (T2 N0 M0) and a case of renal liposarcoma (T3 N0 M0) submitted to surgery and chemo- and radiotherapy. Follow-up at nine months and 4 years, respectively, revealed the patients are tumor-free. The literature is reviewed highlighting the beneficial effect of chemo- and radiotherapy combined with surgery in the treatment of these tumors with a poor prognosis per se.
Zabala Egurrola
J A
JA
Servicio de Urología, Hospital de Cruces, Baracaldo, Vizcaya, España.
Moratalla Basante
A
A
Pertusa Peña
C
C
Arruza Echebarría
A
A
Llarena Ibargue
R
R
Acha Pérez
M
M
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*; D007890:Leiomyosarcoma / Q000628:therapy*; D008080:Liposarcoma / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D011867:Radioisotope Teletherapy; D014750:Vincristine / Q000008:administration & dosage
D003037:Cobalt Radioisotopes; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide
Leiomiosarcoma y liposarcoma: tumores infrecuentes de riñón.